Report released by the Joint UN Programme on HIV/AIDS
A recent report by the Joint United Nations Programme on HIV/AIDS shows the current connection between HIV and tuberculosis(TB) infection around the world.
Every day, more than 4,100 people die from TB and nearly 30,000 people become new-onset TB cases. For patients living with HIV, the probability of developing TB is 18 times higher than that of ordinary people.
From 2018 to 2020, nearly 7.5 million people living with HIV were given preventive TB treatment, meeting the global target of 6 million from 2018 to 2022 ahead of schedule.
TB is the main cause of death among people living with HIV, accounting for around one third of AIDS-related deaths globally. In 2020, an estimated 214,000 people living with HIV died from TB, reducing TB deaths by 62 percent in the group and failing to meet the global target of 75 percent.
HIV testing for both people living with HIV and people with TB is the key to preventing TB-related deaths in the former group.
In 2020, there were an estimated 1.3 million TB deaths among HIV-negative people (up from 1.2 million in 2019) and 214,000 TB deaths among those living with HIV (up from 209,000 in 2019), reflecting the same levels as in 2017.
Of the TB deaths among people living with HIV, 50 percent were men, 40 percent were women and 9.8 percent were children.
Among all incident episodes of TB, 8 percent were among people living with HIV. The proportion of TB episodes coinfected with HIV was higher in countries in the World Health Organization African region, with that of South Africa exceeding 50 percent.
TB-related HIV deaths were reduced by nearly 1.2 million from 2000 to 2020 due to effective interventions.
The global coverage of HIV testing among people diagnosed with TB remained high in 2020, at 73 percent (up from 70 percent in 2019). However, the absolute number of people diagnosed with TB who knew their HIV status fell from 4.8 million in 2019 to 4.2 million in 2020 (a reduction of 15 percent).
In 87 countries and regions around the world, at least 90 percent of people diagnosed with TB knew their HIV status. The coverage of antiretroviral therapy among people diagnosed with TB and known to be HIV-positive was 88 percent in 2020, the same level as in 2019.
Globally, the number of people living with HIV who received TB preventive treatment annually increased from fewer than 30,000 in 2005 to 3 million in 2019, a figure that was reduced by 23 percent between 2019 and 2020 to 2.7 million.
At least 6 million people living with HIV are to receive TB preventive treatment by 2022 (already reached).
90 percent of people living with HIV should receive preventive treatment for TB by 2025.